Home
About
Overview
Sharing Data
ORCID
Help
History (121)
Inhibition of paracetamol glucuronidation by tyrosine kinase inhibitors.
Regulation of Adhesion and Proteolysis in Ovarian Cancer
Acanthocheilonema
Surgical Versus Endovascular Aortic Aneurysm Repair: Evidence to Guide the Optimal Approach for the Individual Patient.
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.
See All 121 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. J Clin Oncol. 2012 Apr 20; 30(12):1321-8.
View in:
PubMed
subject areas
Adult
Age Distribution
Aged
Breast Neoplasms
Cohort Studies
Confidence Intervals
Female
Genes, BRCA1
Genes, BRCA2
Genetic Predisposition to Disease
Genetic Testing
Germ-Line Mutation
Heterozygote
Humans
Incidence
Jews
Middle Aged
Odds Ratio
Ovarian Neoplasms
Prevalence
Prognosis
Proportional Hazards Models
Risk Assessment
Risk Reduction Behavior
authors with profiles
Olufunmilayo Olopade